Inhalation Sciences upgrades Quality Management System to further strengthen company and prepare for increased market requirements
(Stockholm, 14 February 2022) Inhalation Sciences (ISAB) is updating its Quality Management System - strengthening its competitiveness and efficiency in preclinical settings but also preparing for future use in clinical environments. ISAB will implement EN ISO 13485 with full implementation to be completed by June 2022.ISO 13485 implementation is widely recognized as a prestigious and trusted stamp of quality throughout the MedTech industry. It is associated with improved efficiencies, speed and consistency of service and operations – and higher customer satisfaction. ISAB is now